UP!
|
Type
|
Public company |
|---|---|
| Traded as | NASDAQ: PSDV ASX: PVA FWB: PV3 |
| Industry | Pharmaceuticals |
| Headquarters | Watertown, Massachusetts, USA |
|
Number of locations
|
2 |
| Products | Iluvien |
| Website | www |
pSivida is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency (DERA, now QinetiQ). QinetiQ continues to be a strategic partner.
| 2016-06-23 | Reiterated Rating | FBR & Co. | Buy | $7.00 |
| 2016-06-23 | Reiterated Rating | FBR & Co | Buy | $7.00 |
| 2016-05-12 | Reiterated Rating | FBR & Co. | Buy | $6.00 to $7.00 |
| 2015-12-29 | Reiterated Rating | Ladenburg Thalmann | Buy | |
| 2015-12-23 | Reiterated Rating | Ladenburg Thalmann | Buy | |
| 2015-12-17 | Reiterated Rating | Northland Securities | Buy | |
| 2015-10-15 | Initiated Coverage | FBR & Co. | Outperform | $6.00 |
| 2015-07-07 | Reiterated Rating | MLV & Co. | Buy | $6.50 |
| 2015-06-12 | Set Price Target | MLV & Co. | Buy | $6.50 |
| 2015-02-06 | Set Price Target | MLV & Co. | Buy | $6.50 |
| 2014-09-29 | Reiterated | Northland Capital | Outperform | $7 to $10 |
| 2014-09-29 | Boost Price Target | Northland Securities | Outperform | $7.00 to $10.00 |
| 2014-05-05 | Initiated Coverage | MLV & Co. | Buy | $6.00 |
| 2013-12-19 | Boost Price Target | Ladenburg Thalmann | $6.00 | |
| 2013-10-18 | Lower Price Target | Ladenburg Thalmann | Buy | $5.00 to $2.75 |
| 2013-10-08 | Initiated Coverage | Northland Securities | Outperform | $7.00 |
| 2013-10-07 | Initiated Coverage | Northland Securities | Outperform | |
| 2013-04-10 | Upgrade | Ladenburg Thalmann | Neutral to Buy | $4 |
| 2009-11-18 | Initiated | Ladenburg Thalmann | Buy | $9 |
| 2016-06-23 | Reiterated Rating | FBR & Co. | Buy | $7.00 |
| 2016-06-23 | Reiterated Rating | FBR & Co | Buy | $7.00 |
| 2016-05-12 | Reiterated Rating | FBR & Co. | Buy | $6.00 to $7.00 |
| 2015-12-29 | Reiterated Rating | Ladenburg Thalmann | Buy | |
| 2015-12-23 | Reiterated Rating | Ladenburg Thalmann | Buy |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In PSDV 4 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Fund Advisors | 84753 |
| BlackRock Institutional Trust Company, N.A. | 10032 |
| BLACKROCK ADVISORS LLC | 6822 |
| BlackRock Investment Management, LLC | 5318 |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Essex Woodlands Fund IX, L.P. | 29.42% (8606324) | AXGN / PSDV / |
| Ashton Paul Managing Director | 1.54% (450741) | PSDV / |
| Mazzo David J | 0.41% (120500) | AVNR / NBS / PSDV / RGDO / |
| Freedman Lori VP Corp Affairs,Gen Coun & Sec | 0.33% (96423) | PSDV / |
| Lurker Nancy President and CEO | 0.32% (95033) | AUXL / MNK / PDII / PSDV / |
| Ross Leonard S Corporate Controller | 0.03% (10000) | PSDV / |
| Hopper Paul | 0.03% (10000) | PSDV / |
| Paggiarino Dario A. Chief Medical Officer | 0.03% (8333) | LPTN / PSDV / |
UM